Janet Woodcock, FDA, on Biomarker Development and the Future of Clinical Trials

1×

0:00

-27:35

Janet Woodcock, FDA, on Biomarker Development and the Future of Clinical Trials

Nov 13, 2014

Guest: Janet, Woodcock, MD, Director, CDER, FDA
Bio and Contact Info Listen (4:41) No agency charged with better translational outcomes

0 Comments

Mendelspod Podcast

Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.

Listen on

Substack App

Apple Podcasts

RSS Feed

Appears in episode

Theral Timpson

Recent Episodes

26:21

Supercharged Killer Cells Effective Against Alzheimer’s: Paul Song, CEO, NKGen Biotech

Nov 28 •

32:34

Chris Hall and Rich Chen of Personalis on Next Gen MRD Testing

Nov 21 •

59:11

State of Sequencing 2023: Shawn Baker and Keith Robison

Nov 14 •

43:11

Newborn Sequencing 2023 Part II: What Evidence Is Enough?

Nov 7 •

32:19

Lincoln Nadauld on the State of Precision Medicine in 2023

Oct 17 •

18:37

Nothing Is "Undruggable:" Alex Federation, CEO, Talus Bio

Oct 12 •

19:15

Mass Spec Advances in a New Age of Proteomics: Rosy Lee, Thermo Fisher Scientific

Oct 10 •

34:54

This Is Very Cool: Treating Cancer with Sound

Oct 3 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts